MedDataX Logo

CARE Study: Cancer, Asian Americans, and Relationship Enrichment

NCT ID: NCT06782581

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

186 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-06

Study Completion Date

2027-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overarching goal of the current study is to reduce the burden Asian American patients may feel are on their caregivers by designing and testing the feasibility and efficacy of a positive activity intervention designed to increase a sense of autonomy, competence, and connectedness, each of which have been shown to be associated with psychological benefits according to self-determination theory.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will introduce two new positive activities, household contribution and outside contribution, which have been specifically created for AA cancer patients and have not been previously investigated. These interventions have been developed with consideration of culture-related challenges, Hofstede's concept of collectivist cultures, and self-determination theory. This study will be the first randomized controlled trial to assess the impact of these new positive activities on Asian-American cancer patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neoplasm

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Asian American Cancer Patient Positive Activities Well-being Caregiver

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

Participants in the control group will be asked to factually describe either (1) immediate environment, (2) the weather, or (3) organization of closet

Group Type PLACEBO_COMPARATOR

Control

Intervention Type BEHAVIORAL

factually describe either (1) immediate environment, (2) the weather, or (3) organization of closet

Contribution

Contribution to caregiver wellbeing via household tasks. If the household contribution condition is chosen, participants will be given instructions and examples/list of things they could do to contribute to the well-being of their caregiver (e.g., cook a meal, take pet for a walk, water the plants). If the outside contribution condition is chosen, participants will be given instructions and examples/list of things they could do to contribute to the world outside of their own home (e.g., pick up litter in neighborhood, buy coffee for stranger, donate food/clothing to homeless)

Group Type EXPERIMENTAL

Contribution to Caregivers Well-Being

Intervention Type BEHAVIORAL

Contribute to caregiver's well-being via household tasks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Contribution to Caregivers Well-Being

Contribute to caregiver's well-being via household tasks.

Intervention Type BEHAVIORAL

Control

factually describe either (1) immediate environment, (2) the weather, or (3) organization of closet

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Household Contribution Internal Contribution Experimental Arm Control Group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. self-identifies as Asian American or Asian
2. males or females ages 21-80 years
3. within 2 years of any cancer diagnosis or stage 4 cancer diagnosis
4. actively undergoing surgery or systemic therapy (e.g., chemotherapy, radiation, immunotherapy) or within the past 6 months,
5. able to identify a caregiver (e.g., spouse) who lives in the same household or see at least 3 times per week
6. able to read, write, and speak English (i.e., English proficient; EP) or Mandarin/simplified Chinese.


1. identifies as Asian American or Asian,
2. patient considers them to be caregiver
3. English proficient or Mandarin Chinese proficient
4. access to computer/phone, internet, and web browser.

Exclusion Criteria

1. life expectancy less than 6 months in the opinion of the primary physician
2. inability to stand or walk on their own or other physical limitations that preclude them from participating (3+ on ECOG performance status),
3. major thought disorder (e.g., schizophrenia or bipolar \[patient records or self-disclosure\]).


1. unwilling or unable to participate in the study for any reason,
2. under the age of 18.
Minimum Eligible Age

21 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Fox Chase Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lilian Shin-Cho

Principal Investigator, Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fox Chase Cancer Center - Philadelphia

Philadelphia, Pennsylvania, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lilian J. Shin-Cho, PhD

Role: CONTACT

Phone: 267-889-2209

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lilian Shin-Cho, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5R00CA267678-04

Identifier Type: NIH

Identifier Source: secondary_id

View Link

24-1006

Identifier Type: -

Identifier Source: org_study_id